Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
K. Yoshikawa
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
ORCID:
0009-0000-8613-4330
Observed ORCID:
0009-0000-8613-4330
OpenAlex ID:
A5014691195
Hypoalbuminemia during zolbetuximab plus chemotherapy for claudin 18.2-positive advanced gastric cancer: a need for caution?
2025
·
K. Shimozaki
, A. Ooki
, et al.
·
ESMO Gastrointestinal Oncology
·
9
PDF
Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy
2026
·
A. Ooki
, K. Nakano
, et al.
·
ESMO Gastrointestinal Oncology
·
1
PDF
Clinical implications of zolbetuximab-associated hypoalbuminemia in CLDN18.2-positive gastric or gastroesophageal junction cancer
2026
·
A. Ooki
, K. Shimozaki
, et al.
·
ESMO Gastrointestinal Oncology
PDF
109P KRAS G12C versus non-G12C mutated metastatic colorectal cancer: Real-world later-line clinical outcomes
2026
·
K. Yoshikawa
, H. Osumi
, et al.
·
Annals of Oncology
92P Circulating tumor DNA RAS mutant allele frequency as a predictor of efficacy of anti-EGFR monoclonal antibody rechallenge in patients with metastatic colorectal cancer
2026
·
E. Toyokawa
, H. Osumi
, et al.
·
Annals of Oncology
93P Clinical utility of tissue-based negative hyper selection for optimizing targeted therapy in metastatic colorectal cancer
2026
·
K. Suzuki
, H. Osumi
, et al.
·
Annals of Oncology
PDF
604P Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: Follow-up data from real-world experience
2026
·
K. Shimozaki
, O. Akira
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
7
Citation count:
10
H-index:
1
I10-index:
Year
Topic
Type